Canadian Sec - Free Realtime Quote CAD

Green Thumb Industries Inc. (GTII.CN)

9.07 +0.37 (+4.25%)

As of 10:48:36 AM EST. Market Open.

Chart Range Bar

Loading chart for GTII.CN

Previous Close 8.70
Open 8.70
Bid 8.95 x --
Ask 8.98 x --
Day's Range 8.70 - 9.07
52 Week Range 7.40 - 14.39
Volume 98,343
Avg. Volume 149,960
Market Cap (intraday) 1.983B
Beta (5Y Monthly) 1.14
PE Ratio (TTM) 12.13
EPS (TTM) 0.75
Earnings Date Nov 4, 2026
Forward Dividend & Yield -- (0.00%)
Ex-Dividend Date --
1y Target Est 21.01

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, capsules, tinctures, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, RYM, and RHYTHM brands. It distributes its products to third-party licensed retail customers; and sells finished products to third-party licensed retail cannabis stores. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.

www.gtigrows.com

4,900

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Drug Manufacturers - Specialty & Generic

Industry

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

GTII.CN

18.39%

S&P/TSX Composite index (^GSPTSE)

12.84%

1-Year Return

GTII.CN

8.63%

S&P/TSX Composite index (^GSPTSE)

18.83%

3-Year Return

GTII.CN

25.29%

S&P/TSX Composite index (^GSPTSE)

83.22%

5-Year Return

GTII.CN

63.01%

S&P/TSX Composite index (^GSPTSE)

69.86%

Earnings Per Share

gaap GAAP

nongaap Normalized

gaap GAAP

nongaap Normalized

Revenue vs. Earnings

yearly Annual

quarterly Quarterly

yearly Annual

quarterly Quarterly

Q2 FY26

Revenue 306.68M

Earnings 4.88M

Profit Margin 1.59%

FY25

FY26

100M

200M

300M

5.0%

10.0%

15.0%

20.0%

25.0%

Analyst Price Targets

17.86

21.01 Average

9.07 Current

24.89 High

Analyst Recommendations

Strong Buy
Buy
Hold
Underperform
Sell

Latest Rating

Date 5/10/2024

Analyst Wedbush

Rating Action Maintains

Rating Outperform

Price Action Raises

Price Target 15 -> 16

Valuation Measures

  
  
 Annual 

Market Cap
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (current)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

Profit Margin

10.48%
Return on Assets (ttm)

2.71%
Return on Equity (ttm)

6.85%
Revenue (ttm)

1.21B
Net Income Avi to Common (ttm)

126.77M
Diluted EPS (ttm)

0.75

Balance Sheet and Cash Flow

Total Cash (mrq)

283.59M
Total Debt/Equity (mrq)

30.11%
Levered Free Cash Flow (ttm)

151.48M

CL.CN

IAN.CN

CRON.TO

CWEB.TO

PLTH.CN

U.S. markets close in 4h 39m

Green Thumb Industries Inc. (GTII.CN)

1.90%

-4.71%

-16.28%

-18.39%

-8.63%

-63.01%

-99.30%

Green Thumb Industries Inc. Overview Drug Manufacturers - Specialty & Generic / Healthcare

Full Time Employees

Fiscal Year Ends

Sector

Industry

Recent News

Performance Overview

YTD Return

1-Year Return

3-Year Return

5-Year Return

Earnings Trends

Earnings Per Share

Revenue vs. Earnings

Analyst Insights

Analyst Price Targets

Analyst Recommendations

Latest Rating

Statistics

Valuation Measures

Financial Highlights

Profitability and Income Statement

Balance Sheet and Cash Flow

Company Insights

Research Reports

People Also Watch